VR-Enhanced EMDR for PTSD: A Feasibility Study

  • Research type

    Research Study

  • Full title

    A Multi-Centre, Randomised Controlled Feasibility Trial Comparing VR-Enhanced Blended Care versus Standard EMDR Therapy for Adults with Post-Traumatic Stress Disorder (PTSD)

  • IRAS ID

    365747

  • Contact name

    Francis Madden

  • Contact email

    francis@reinhart.uk

  • Sponsor organisation

    Reinhart

  • Clinicaltrials.gov Identifier

    10.17605/OSF.IO/BM5VF, OSF Preregistration

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    Post-Traumatic Stress Disorder (PTSD) can be very distressing, and while a standard treatment called EMDR helps many people, it is often limited by clinician availability. This study tests whether providing patients with a Virtual Reality (VR) headset to use at home, alongside their standard therapy, can safely and effectively improve outcomes.We will recruit 64 adults with PTSD from 4 sites (1 NHS and 2 private).

    They will be randomly placed into one of two groups for a 6-week treatment period:

    Control Group: Will receive 6 weekly sessions of standard in-person EMDR therapy.

    Intervention Group: Will receive standard weekly in-person EMDR therapy, but in addition, they will be given a VR headset (called "EMDR-VR") to take home for a 3-week period. During this time, they will be asked to complete therapeutic "homework" exercises lasting 40-50 minutes, roughly 3 to 4 times a week (every other day).

    We will ask participants to complete questionnaires about their symptoms at the start, middle, and end of their treatment. The VR device is CE-marked and currently recognised for use in Great Britain. This is a feasibility study to see if this "blended care" (clinic + home) approach is acceptable and safe for patients, and to gather preliminary data Real-World Evidence (RWE) to support a future UKCA mark application.

  • REC name

    South East Scotland REC 02

  • REC reference

    26/SS/0056

  • Date of REC Opinion

    10 Jun 2026

  • REC opinion

    Further Information Favourable Opinion